These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 2190427)
21. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud. Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659 [TBL] [Abstract][Full Text] [Related]
28. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438 [TBL] [Abstract][Full Text] [Related]
29. Inadequate treatment of opioid dependence due to society's attitudes and beliefs. Blansfield HN Conn Med; 1996 Jul; 60(7):423-8. PubMed ID: 8758660 [TBL] [Abstract][Full Text] [Related]
30. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule. Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334 [TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of methadone maintenance. Barnett PG; Hui SS Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486 [TBL] [Abstract][Full Text] [Related]
33. Methadone and naltrexone in the treatment of heroin dependence. Greenstein RA; Resnick RB; Resnick E Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309 [TBL] [Abstract][Full Text] [Related]
34. Low efficacy of non-opioid drugs in opioid withdrawal symptoms. Hermann D; Klages E; Welzel H; Mann K; Croissant B Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669 [TBL] [Abstract][Full Text] [Related]
35. [Discussion on methadone programs in the Federal Republic of Germany]. Schönhöfer PS; Hasse HE Dtsch Med Wochenschr; 1973 Oct; 98(43):2038-43. PubMed ID: 4200683 [No Abstract] [Full Text] [Related]
36. [Quality of life for drug abusers accepting methadone maintenance treatment]. Li XL; Tan HZ; Sun ZQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):601-5. PubMed ID: 18667773 [TBL] [Abstract][Full Text] [Related]
37. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Harper RG; Solish GI; Purow HM; Sang E; Panepinto WC Pediatrics; 1974 Sep; 54(3):300-5. PubMed ID: 4416175 [No Abstract] [Full Text] [Related]
38. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397 [TBL] [Abstract][Full Text] [Related]
39. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients? Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244 [TBL] [Abstract][Full Text] [Related]
40. Pregnancy in the context of narcotic addiction and methadone maintenance. Davis RC; Chappel JN Proc Natl Conf Methadone Treat; 1973; 2():1146-52. PubMed ID: 4808261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]